Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance study
Author:
Affiliation:
1. Department of Pharmacy Fudan University Shanghai Cancer Center Shanghai China
2. Department of Oncology Shanghai Medical College, Fudan University Shanghai China
Publisher
Wiley
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13777
Reference32 articles.
1. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
2. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
3. Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer
4. CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas
5. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adverse effect of trastuzumab deruxtecan in solid tumours: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2025-09
2. Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges;Journal of Neuro-Oncology;2025-06-05
3. A Systematic Review of Mechanisms, Incidence, and Management of Trastuzumab Deruxtecan Induced ILD/Pneumonitis in Solid Tumors;Drug Design, Development and Therapy;2025-03
4. The Icarian flight of antibody-drug conjugates: target selection amidst complexity and tackling adverse impacts;Protein & Cell;2025-02-25
5. Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities;Clinical and Translational Science;2025-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3